UK Companies House feature
RSR LIMITED
Cash
£20M
-15.8% vs 2022
Net assets
£32M
+2.1% vs 2022
Employees
96
-3% vs 2022
Profit before tax
£19M
-23.7% vs 2022
Profile
- Company number
- 03766047
- Status
- Active
- Incorporation
- 1999-05-07
- Last accounts made up
- 2024-09-30
- Account category
- FULL
- Primary SIC
- 21100
- Hubs
- UK Healthcare
Net assets
6-year trend · vs UK Healthcare median
Accounts
6-year trend · latest 2023-09-30
| Metric | Trend | 2018-09-30 | 2019-09-30 | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 |
|---|---|---|---|---|---|---|---|
| Turnover | — | — | — | — | £24,400,827 | £22,176,065 | |
| Operating profit | — | — | — | — | £25,443,139 | £19,437,701 | |
| Profit before tax | — | — | — | — | £25,538,146 | £19,491,069 | |
| Net profit | — | — | — | — | £21,990,101 | £17,656,521 | |
| Cash | — | — | — | — | £23,280,723 | £19,608,167 | |
| Total assets less current liabilities | — | — | — | — | £31,656,731 | £32,293,736 | |
| Net assets | — | — | — | — | £31,607,646 | £32,264,167 | |
| Equity | £18,884,437 | £21,570,898 | £22,581,961 | £23,617,545 | £31,607,646 | £32,264,167 | |
| Average employees | — | — | — | — | 99 | 96 | |
| Wages | — | — | — | — | £4,970,796 | £5,331,173 |
Values shown as filed in iXBRL accounts. — indicates the figure was not present in the extracted filing (either not filed under that concept or absent from the period). About these numbers
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- Bishop Fleming Audit Limited
- Audit opinion
- Qualified
- Going concern
- Affirmed
“The financial statements have been prepared on a going concern basis which assumes that the company will continue in operational existence for the foreseeable future. In making their assessment, the directors have reviewed the balance sheet, the likely future cashflows of the business and have considered the facilities that are available to the company along with their continued support. At the date of approving the financial statements the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future and that the going concern basis of accounting remains appropriate.”
Subsidiaries
- AV7 Limited · 80% held · England · Developing and producing therapeutic products
Significant events
- “Counter Indemnity was given by the company's banker, HSBC Bank for £40,000 (2023: £40,000) to HM Customs and Exercise.”
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
6 active · 10 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| BOAK, Jenny Louise | Secretary | 2023-11-24 | — | — |
| BOAK, Jenny Louise | Director | 2025-10-30 | Nov 1987 | British |
| BRADBURY, Janet | Director | 2016-08-23 | Oct 1966 | British |
| CHEN, Shu, Dr | Director | 2016-08-23 | Aug 1966 | British |
| REES SMITH, Bernard, Dr | Director | 1999-06-15 | Jun 1944 | British |
| SANDERS, Jane, Dr | Director | 2016-08-23 | Nov 1966 | British |
Show 10 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| BARWISE, Jenny Louise | Secretary | 2016-07-25 | 2022-09-30 |
| BECK, Gillian | Secretary | 2000-07-31 | 2016-05-11 |
| CARTER, Lynn | Secretary | 2022-09-30 | 2023-11-24 |
| REES SMITH, Bernard, Dr | Secretary | 1999-06-15 | 2000-07-31 |
| SEVERNSIDE SECRETARIAL LIMITED | Corporate Nominee Secretary | 1999-05-07 | 1999-06-15 |
| BECK, Gillian | Director | 2009-10-14 | 2016-05-11 |
| FURMANIAK, Jadwiga, Dr | Director | 2016-08-23 | 2022-05-31 |
| POWELL, Michael, Dr | Director | 2016-08-23 | 2022-05-31 |
| REES-SMITH, Jean | Director | 1999-06-15 | 2009-07-24 |
| SEVERNSIDE NOMINEES LIMITED | Corporate Nominee Director | 1999-05-07 | 1999-06-15 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Dixondale Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2025-04-30 | Active |
| Dr Bernard Rees-Smith | Individual | Shares 75–100% | 2016-04-06 | Ceased 2025-04-30 |
Filing timeline
Last 20 of 95 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2025-11-06 | CH03 | officers | change person secretary company with change date |
| 2025-11-06 | AP01 | officers | appoint person director company with name date |
| 2025-10-06 | AA | accounts | accounts with accounts type full |
| 2025-05-27 | PSC07 | persons-with-significant-control | cessation of a person with significant control |
| 2025-05-27 | AD03 | address | move registers to sail company with new address |
| 2025-05-27 | AD02 | address | change sail address company with new address |
| 2025-05-23 | PSC02 | persons-with-significant-control | notification of a person with significant control |
| 2025-05-23 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2024-06-28 | AA | accounts | accounts with accounts type full |
| 2024-05-24 | CS01 | confirmation-statement | confirmation statement with updates |
| 2023-11-24 | AP03 | officers | appoint person secretary company with name date |
| 2023-11-24 | TM02 | officers | termination secretary company with name termination date |
| 2023-09-01 | AA | accounts | accounts with accounts type full |
| 2023-05-11 | CS01 | confirmation-statement | confirmation statement with updates |
| 2022-10-20 | TM02 | officers | termination secretary company with name termination date |
| 2022-10-19 | AP03 | officers | appoint person secretary company with name date |
| 2022-06-28 | AA | accounts | accounts with accounts type full |
| 2022-06-01 | TM01 | officers | termination director company with name termination date |
| 2022-06-01 | TM01 | officers | termination director company with name termination date |
| 2022-05-13 | CS01 | confirmation-statement | confirmation statement with updates |
Credit score
Altman Z″ (private-firm) · reference 2023-09-30
41.10
SAFE
Altman Z″
- Working capital / Total assets 0.959 × 6.56 = +6.29
- Retained earnings / Total assets 0.000 × 3.26 = +0.00
- EBIT / Total assets 0.583 × 6.72 = +3.92
- Book equity / Total liabilities 29.425 × 1.05 = +30.90
Bands: > 2.6 safe · 1.1–2.6 grey · < 1.1 distress. Z″ is a public-formula baseline, not a substitute for adverse-data signals (CCJs, charges, gazette notices) — those land in a later pass.
Activity Score
Filings velocity, capital events, officer churn, accounts trajectory